Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 47, 2018 - Issue 5
Submit an article Journal homepage
436
Views
8
CrossRef citations to date
0
Altmetric
Letters

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B GlintborgThe Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark;Department of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Gentofte, DenmarkCorrespondence[email protected]
View further author information
,
T KringelbachThe Danish Rheumatologic Biobank, Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, DenmarkView further author information
,
N BolstadDepartment of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, NorwayView further author information
,
DJ WarrenDepartment of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, NorwayView further author information
,
G EngDepartment of Rheumatology, Zealand University Hospital, Køge, DenmarkView further author information
,
IJ SørensenThe Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark;Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
,
AG LoftDepartment of Rheumatology, Aarhus University Hospital, Aarhus, DenmarkView further author information
,
O HendricksKing Christian X’s Hospital for Rheumatic Diseases, Graasten, DenmarkView further author information
,
IMJ HansenDepartment of Rheumatology, Odense University Hospital, Svendborg Hospital, Svendborg, DenmarkView further author information
,
A LinauskasDepartment of Rheumatology, North Denmark Regional Hospital, Hjørring, DenmarkView further author information
,
H NordinDepartment of Rheumatology, Zealand University Hospital, Køge, DenmarkView further author information
,
S KristensenDepartment of Rheumatology, Aalborg University Hospital, Aalborg, DenmarkView further author information
,
H LindegaardDepartment of Rheumatology, Odense University Hospital, Odense, DenmarkView further author information
,
DV JensenDepartment of Rheumatology, Gentofte and Herlev Hospital, Copenhagen University Hospital, Gentofte, DenmarkView further author information
,
GL GollDepartment of Rheumatology, Diakonhjemmet Hospital, Oslo, NorwayView further author information
,
E HøgdallThe Danish Rheumatologic Biobank, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, DenmarkView further author information
,
J GehinDepartment of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, NorwayView further author information
,
C EnevoldCenter for Rheumatology and Spine Diseases, Institute for Inflammation Research (IIR), Rigshospitalet, Copenhagen University Hospital, Glostrup, DenmarkView further author information
,
CH NielsenCenter for Rheumatology and Spine Diseases, Institute for Inflammation Research (IIR), Rigshospitalet, Copenhagen University Hospital, Glostrup, DenmarkView further author information
,
NS KroghZitelab, Copenhagen, DenmarkView further author information
,
JS JohansenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;The Danish Rheumatologic Biobank, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark;Department of Medicine and Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, DenmarkView further author information
&
ML HetlandThe Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark;Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
 show all
Pages 418-421 | Accepted 01 Sep 2017, Published online: 09 Jan 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ji-Won Kim, Ju-Yang Jung & Chang-Hee Suh. (2021) Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review. Expert Opinion on Biological Therapy 21:1, pages 57-73.
Read now

Articles from other publishers (7)

Anita Afzali, Daniel Furtner, Richard Melsheimer & Philip J. Molloy. (2021) The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Advances in Therapy 38:5, pages 2077-2093.
Crossref
Ambre Lauret, Anna Moltó, Vered Abitbol, Loriane Gutermann, Ornella Conort, François Chast, Claire Goulvestre, Claire Le Jeunne, Stanislas Chaussade, Christian Roux, Frédéric Batteux, Maxime Dougados, Yannick Allanore & Jérôme Avouac. (2020) Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice. Seminars in Arthritis and Rheumatism 50:6, pages 1449-1456.
Crossref
Thomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder, Birgitte Klindt Poulsen, Stig Ejdrup Andersen, Mette Marie H. Christensen, Lars Nielsen & Hanne Rolighed Christensen. (2019) The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars. European Journal of Clinical Pharmacology 76:1, pages 35-40.
Crossref
G. L. Goll, K. K. Jørgensen, J. Sexton, I. C. Olsen, N. Bolstad, E. A. Haavardsholm, K. E. A. Lundin, K. S. Tveit, M. Lorentzen, I. P. Berset, B. T. S. Fevang, S. Kalstad, K. Ryggen, D. J. Warren, R. A. Klaasen, Ø. Asak, S. Baigh, I. M. Blomgren, Ø. Brenna, T. J. Bruun, K. Dvergsnes, S. O. Frigstad, I. M. Hansen, I. S. H. Hatten, G. Huppertz‐Hauss, M. Henriksen, S. S. Hoie, J. Krogh, I. P. Midtgard, P. Mielnik, B. Moum, G. Noraberg, A. Poyan, U. Prestegård, H. U. Rashid, E. K. Strand, K. Skjetne, K. A. Seeberg, R. Torp, C. M. Ystrøm, C. Vold, C. C. Zettel, K. Waksvik, B. Gulbrandsen, J. Hagfors, C. Mørk, J. Jahnsen & T. K. Kvien. (2019) Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial. Journal of Internal Medicine 285:6, pages 653-669.
Crossref
Evrydiki Kravvariti, George D. Kitas, Dimos D. Mitsikostas & Petros P. Sfikakis. (2018) Nocebos in rheumatology: emerging concepts and their implications for clinical practice. Nature Reviews Rheumatology 14:12, pages 727-740.
Crossref
Tina Marie Kringelbach, Bente Glintborg, Estrid V Hogdall, Julia Sidenius Johansen & Merete Lund Hetland. (2018) Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study. BMJ Open 8:2, pages e019325.
Crossref
Paul Chamberlain & Pekka Kurki. 2018. Biosimilars. Biosimilars 489 542 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.